2020 / 05

Next Paper
DOI: 10.24075/brsmu.2020.062

CLINICAL CASE

Difficulties in differential diagnosis of cutaneous manifestations in patients with coronavirus infection

Tairova RT1,2, Gaydina TA1,2, Dvornikov AS2, Tazartukova AD1, Lyang OV1
About authors

1 Federal Center for Brain and Neurotechnology of FMBA of Russia, Moscow, Russia

2 Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Tatiana A. Gaydina
Ostrovityanova, 1, Moscow, 117997; ur.xednay@924cod

About paper

Compliance with ethical standards: the patient gave informed consent to medical treatment and publication of this case report.

Author contribution: Tairova RT, Gaydina TA: interpretation of the obtained data, manuscript draft; Dvornikov AS: literature analysis; Tazartukova AD: interpretation of the obtained data; Lyang OV: manuscript draft.

Received: 2020-09-23 Accepted: 2020-10-08 Published online: 2020-10-21
|
  1. Casas C, Catala A, Hernandez G, Rodríguez-Jimenez P, Nieto D, Rodriguez-Villa A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. British Journal of Dermatology. 2020; 183 (1): 71–77. DOI: 10.1111/bjd.19163.
  2. Almutairi N, Schwartz RA. COVID-2019 with dermatologic manifestations and implications: an unfolding conundrum. Dermatol Therapy. 2020; e13544. Available from: https://doi. org/10.1111/dth.13544.
  3. Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, et al. Acral cutaneous lesions in the time of COVID-19. J Eur Acad Dermatol Venereol. 2020; 34 (8): e346– e347. DOI: 10.1111/jdv.16533.
  4. Criado PR, Abdalla BMZ, Assis IC, Blarcum de Graaff Mello C, Caputo GC, Vieira IC. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res. 2020; 69 (8): 745–56. DOI: 10.1007/s00011-020-01370-w.
  5. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020; 395 (10223): 470–73. DOI: 10.1016/S0140-6736(20)30185-9.
  6. Formica D, Sultana J, Cutroneo P, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf. 2018; 17 (7): 681– 95. DOI: 10.1080/14740338.2018.1491547
  7. Aung A, Tang M, Adler N, et al. Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting. The Journal of Clinical Pharmacology. 2018; 58 (10): 1332–9. DOI: 10.1002/jcph.1148.
  8. Gelincik A, Brockow K, Celik GE, Dona I, Mayorga C, Romano A, et al. Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19. Allergy. 2020; 10.1111/ all.14439. DOI: 10.1111/all.14439.
  9. Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. British Journal of Dermatology. 2020; 183 (3): 431–42. DOI: 10.1111/bjd.19264.
  10. Su CJ, Lee CH. Viral exanthem in COVID-19, a clinical enigma with biological significance. J Eur Acad Dermatol Venereol. 2020; 34 (6): e251–e252. DOI: 10.1111/jdv.16469.
  11. Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatol Venereol. 2020; 34 (6): e244–e245. DOI: 10.1111/jdv.16472.
  12. Tang K, Wang Y, Zhang H, Zheng Q, Fang R, Sun Q. Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review. Dermatol Ther. 2020: e13528. DOI: 10.1111/ dth.13528.
  13. Vremennye metodicheskie rekomendacii ‘Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19)’. Versija 8.1 (01.10.2020), utverzhdennye Ministerstvom zdravoohranenija RF. Available from: https://static-0.minzdrav.gov.ru/system/ attachments/attaches/000/052/219/original/%D0%92%D1% 80%D0%B5%D0%BC%D0%B5%D0%BD%D0%BD%D1% 8B%D0%B5_%D0%9C%D0%A0_COVID-19_%28v.8.1%29. pdf?1601561462. Russian.
  14. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020; 34 (5): e212– e213. DOI: 10.1111/jdv.16387.
  15. Jimenez-Cauhe J, Ortega-Quijano D, Prieto-Barrios M, Moreno- Arrones OM, Fernandez-Nieto D. Reply to "COVID-19 can present with a rash and be mistaken for dengue": Petechial rash in a patient with COVID-19 infection. J Am Acad Dermatol. 2020; 83 (2): e141–e142. DOI: 10.1016/j.jaad.2020.04.016.
  16. Diaz-Guimaraens B, Dominguez-Santas M, Suarez-Valle A, Pindado-Ortega C, Selda-Enriquez G, Bea-Ardebol S, et al. Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. JAMA Dermatol. 2020; 156 (7): 820–22. DOI: 10.1001/jamadermatol.2020.1741.